Navigation Links
NOVAVAX to Present at the Influenza Congress USA 2009
Date:11/11/2009

ROCKVILLE, Md., Nov. 11 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) a clinical-stage vaccine company, announced today that John Trizzino, Senior Vice President, International and Government Alliances, will be presenting at the Influenza Congress USA 2009. Mr. Trizzino's presentation will take place at 3:30 pm local time on November 20, 2009 at The Westin Washington, Washington D.C. Mr. Trizzino will be discussing regional partnership drivers, benefits of regional partnerships and value-creation through regional partnerships in a Case Study titled: Regional partners as a unique commercialization strategy.

About the Influenza Congress USA 2009

Influenza Congress USA is an annual influenza conference in North America addressing every aspect of influenza policy and planning, influenza research, development and stakeholder partnerships. The influenza vaccine is the fastest growing segment in the adult vaccine market and the United States accounts for over 50% of the global vaccine market. Annually, more than 3.5 million people die of influenza. By 2016, this market is expected to grow to $4.4 billion. H1N1 remains the most immediate threat.

About Novavax

Novavax, Inc. is a clinical-stage biotechnology company, creating novel vaccines to address a broad range of infectious diseases worldwide, including H1N1, using advanced proprietary virus-like-particle (VLP) technology. The company produces potent VLP -based recombinant vaccines utilizing new and efficient manufacturing approaches. Novavax is committed to using its VLP technology to create country-specific vaccine solutions. The Company has formed a joint venture with Cadila Pharmaceuticals, named CPL Biologicals, to develop and manufacture vaccines, biological therapeutics and diagnostics in India. Additional information about Novavax is available on the company's website: www.novavax.com

SOURCE Novavax, Inc.


'/>"/>
SOURCE Novavax, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Beacon Equity Researches: Sanofi-Aventis, Amazon, Yahoo, Johnson & Johnson, Novavax and NexMed
2. Novavax Announces Closing of $11 Million Common Stock Sale to Subsidiary of Cadila Pharmaceuticals
3. Novavax Reports Fourth Quarter and 2008 Year-End Financial Results
4. Novavax Announces Release Date of 2007 Fourth Quarter, Full Year Financial Results and Investor Conference Call
5. Novavax CEO to Present at the Partnering for Global Health Forum
6. Novavax CEO to Present at Susquehannas Second SIGnificant Options in Healthcare Conference
7. Novavax Announces Release Date of 2007 Third Quarter Financial Results and Investor Conference Call
8. Novavax and Allergan Terminate Manufacturing Supply Agreement for Estrasorb
9. Novavax CEO to Present at the 2007 UBS Global Life Sciences Conference
10. American Academy of Physician Assistants Applauds U.S. House of Representatives for Passing Health Care Reform Bill
11. Tyco International to Present at the Citi Industrial Manufacturing & Transportation Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Maryland (PRWEB) , ... June 24, 2016 , ... ... Angels is actively feeding the Frederick area economy by obtaining investment capital for ... over the past 2½ years that have already resulted in more than a ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... the upcoming 2016 Miss Arizona pageant as its official Medspa Sponsor. Dr. Josh ... Mesa, and Chandler, Arizona. , Dr. Olson says the decision to support ...
(Date:6/24/2016)... ... ... Today, InhaleLabs.com (Inhale) offilially launched its site, which aims to ... high quality water pipes within an ideal price range. The site is completely free ... two brothers, Nick and Mike Hunter, who use medical cannabis to heal ailments of ...
(Date:6/23/2016)... CA (PRWEB) , ... June 23, 2016 , ... An ... that may expose a possible link between head and neck cancer in individuals with ... in the study were evaluated based on whether they had gum disease, brushed their ...
(Date:6/23/2016)... McKinney, Texas (PRWEB) , ... June 23, 2016 , ... ... the special operations community. He turned towards the water to find peace and set ... funds for a veterans charity and turned to the internet. He came across the ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... , June 23, 2016 Bracket , ... launch its next generation clinical outcomes platform, Bracket eCOA (SM) ... held on June 26 – 30, 2016 in ... first electronic Clinical Outcome Assessment product of its kind to ... #715. Bracket eCOA 6.0 is a flexible platform ...
(Date:6/23/2016)... and INDIANAPOLIS , June ... receiving a Lilly Diabetes Tomorrow,s Leaders Scholarship is any ... scholarship winners, announced today online at www.diabetesscholars.org ... type 1 diabetes stand in the way of academic ... supported the Foundation,s scholarship program since 2012, and continues ...
Breaking Medicine Technology: